Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report

American Journal of Perinatology
Phyllis ChangMary Stephenson

Abstract

Obstetrical antiphospholipid syndrome (APS) is associated with maternal and fetal morbidity and mortality. Standard treatment with low-dose acetylsalicylic acid and unfractionated heparin has achieved up to a 70 to 80% likelihood of success. Conversely, up to 30% of women with APS will have further pregnancy losses, despite treatment. Intravenous immunoglobulin (IVIG) may be a promising adjuvant when standard treatment fails. We present a case of a 35-year-old woman with obstetrical APS and maternal floor infarction in prior pregnancy losses who continued to have further unsuccessful pregnancies despite standard treatment with acetylsalicylic acid and unfractionated heparin. On an investigational basis, she was prescribed concomitant IVIG and had two subsequent healthy newborns. IVIG appears to be promising in obstetrical patients with APS who are refractory to standard treatment. Prior history of maternal floor infarction may be a prognostic indicator for triple therapy for obstetrical APS.

Citations

Jul 4, 2012·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Adrienne Carruth GriffinLinda M Ernst
Aug 1, 2013·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Rebecca L LinnLinda M Ernst
Apr 22, 2015·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Tinnakorn ChaiworapongsaSonia S Hassan
Mar 1, 2013·Surgical Pathology Clinics·Ona Marie Faye-Petersen, Linda M Ernst
Jul 15, 2009·Seminars in Arthritis and Rheumatism·Yoav ArnsonHoward Amital
Dec 3, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Amelia RuffattiGiustina De Silvestro
May 29, 2007·Seminars in Perinatology·Wendy L Kinzler, Lillian Kaminsky
Oct 10, 2013·The Journal of Obstetrics and Gynaecology Research·Nada Al-SahanAndrée Gruslin
Dec 23, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Athena Chen, Drucilla J Roberts
Jul 12, 2017·International Journal of Surgical Pathology·Ona Faye-PetersenDebra S Heller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.